Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 69.86m |
Free float | 69.26m |
P/E (TTM) | -- |
Market cap | 1.47bn USD |
EPS (TTM) | -2.90 USD |
Data delayed at least 15 minutes.
More ▼
Press releases
- Xencor Announces Closing of Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Xencor Announces Pricing of $175 Million Public Offering of Common Stock
- Xencor Announces Proposed Public Offering of Common Stock
- Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near-Term Clinical Plans and Shares Clinical Progress in Early-Stage Oncology Programs
- Xencor to Host Research & Development Webcast and Conference Call on Monday, September 9, 2024
- Xencor Reports Second Quarter 2024 Financial Results
More ▼